-
Q BioMed Technology Partner Mannin Research Enters Into Collaboration With McMaster University for Glaucoma Drug Candidate MAN-01
firstwordpharma
January 28, 2019
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that its technology partner, Mannin Research, has initiated a collaboration with McMaster University of Ontario, Canada.
-
Q BioMed Technology Partner Mannin Research Enters Into Collaboration With McMaster University for Glaucoma Drug Candidate MAN-01
firstwordpharma
January 28, 2019
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that its technology partner, Mannin Research, has initiated a collaboration with McMaster University of Ontario, Canada.
-
Nicox and Ocumension partner to develop and commercialise glaucoma drug
pharmaceutical-technology
December 18, 2018
French ophthalmology firm Nicox has partnered with China-based Ocumension Therapeutics to develop and commercialise its NCX 470 for the treatment of patients with glaucoma or ocular hypertension......
-
Could a glaucoma drug also fight obesity?
fiercebiotech
August 13, 2018
Scientists have examined many ways to “beige” unhealthy white fat, turning it into energy-burning brown fat to fight obesity. But what if we could stop fat from entering body tissues in the first place.....